Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

BACKGROUND: Little is known regarding the efficacy of immune checkpoint inhibitors (ICI) in patients with advanced large-cell neuroendocrine lung carcinoma (aLCNEC). METHODS: 125 consecutive patients with aLCNEC were identified in the electronic databases of 4 participating cancer centers. The patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudnik, Elizabeth, Kareff, Samuel, Moskovitz, Mor, Kim, Chul, Liu, Stephen V, Lobachov, Anastasiya, Gottfried, Teodor, Urban, Damien, Zer, Alona, Rotem, Ofer, Onn, Amir, Wollner, Mira, Bar, Jair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893659/
https://www.ncbi.nlm.nih.gov/pubmed/33597218
http://dx.doi.org/10.1136/jitc-2020-001999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893659/
https://www.ncbi.nlm.nih.gov/pubmed/33597218
http://dx.doi.org/10.1136/jitc-2020-001999

Ejemplares similares